150 "/"

: Ilaris 150 Mg/ml. ?  »
|
-

S.C

Powder For Solution For Injection

Cryopyrin - Associated Periodic Syndromes (CAPS) in adults, adolescents and children aged 2 years and older with body weight above 7.5 kg, including : - Mucle - wells syndrome (MWS), - Neonatal-onset multisystem inflammatory disease (NOMID) / Chronic infantile neurological, cutaneous, articular syndrome (CINCA), - Severe forms of familial cold autoinflammatory syndrome (FCAS) / Familial cold urticaria (FCU) presenting with signs and symptoms beyond cold-induced urticarial skin rash.Gouty arthritis:Ilaris is indicated for the symptomatic treatment of adults patients with frequent gouty arthritis attacks (at least 3 attacks in the previous 12 months) in whom non-steroidal anti-inflammatory drugs (NSAIDs) and colchicine are contraindicated, are not tolerated, or do not provide an adequate response, and in whom repeated courses of corticosteroids are not appropriate.-Systemic Juvenile Idiopathic Arthritis (SJIA)ILARIS is indicated for the treatment of active Systemic Juvenile Idiopathic Arthritis (SJIA) in patients aged 4 years and older

144 60 32964 00

Novartis Pharma Stein Ag, Switzerland

10/2010 - 09/2015

.
, .
.
/
Canakinumab 150 MG / 1 ML
Vial 6 ml glass type i 1 x VIAL 36
Vial 6 ml glass type i 4 x VIAL 36

*

*

 

.

 
" !
 

?

!
!
 »
190
-